ghk-cu nasal Spray Compounded GHK-Cu Nasal Spray —

Oral Dosing Runs Higher Injectable: 200 to 500mcg per dose Oral: 500 to 1,000mcg per dose, once or twice daily, taken on an empty stomach Higher oral doses are used to make up for the fact that the gut absorbs the compound poorly compared to injections

Peptides in this category act on these different stages: BPC-157 stimulates angiogenesis and tendon healing, TB-500 (Thymosin Beta-4) regulates actin and reduces fibrosis, ARA-290 targets neuroprotection via the EPO-R/CD131 receptor, and VIP modulates inflammation via the VPAC1/VPAC2 receptors

Tirzepatide commonly causes nausea, vomiting, constipation, and reduced appetite, especially at dose initiation

This product is currently on backorder and will delay your order by 3 to 5 business days

Once neurological symptoms have resolved or stabilized, your doctor may consider transitioning you to oral maintenance therapy [4]